Lumiere Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $14.9M

  • Investors
  • 6

Lumiere Therapeutics General Information

Description

Developer of human genetic diagnosis and therapy tools designed for the biotechnology sector. The company's technology focuses on developing gene editing and delivery tools, enabling healthcare providers to treat genetic conditions, recreate patient immunity and delay organ aging through advanced molecular science.

Contact Information

Website
www.ltcure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 315, Building A4, Biopharmaceutical Industrial Park
  • Number. 218 Xinghu Street
  • Suzhou, Jiangsu 215028
  • China
+86 159
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • Room 315, Building A4, Biopharmaceutical Industrial Park
  • Number. 218 Xinghu Street
  • Suzhou, Jiangsu 215028
  • China
+86 159

Lumiere Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lumiere Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 09-Sep-2026 $14.9M Completed Generating Revenue
2. Early Stage VC 08-Jan-2025 Completed Generating Revenue
1. Seed Round 13-Dec-2021 $11.7M $11.7M Completed Startup
To view Lumiere Therapeutics’s complete valuation and funding history, request access »

Lumiere Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lumiere Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Essential Capital (China) Venture Capital Minority
Hangzhou Huafang Chuanghuang Investment Management Corporate Venture Capital Minority
Nanjing Innovation Capital Group Venture Capital Minority
Guangzhou Industrial Investment Holding Group Government Minority
Apricot Capital (Shanghai) Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Lumiere Therapeutics FAQs

  • When was Lumiere Therapeutics founded?

    Lumiere Therapeutics was founded in 2021.

  • Where is Lumiere Therapeutics headquartered?

    Lumiere Therapeutics is headquartered in Suzhou, China.

  • What is the size of Lumiere Therapeutics?

    Lumiere Therapeutics has 10 total employees.

  • What industry is Lumiere Therapeutics in?

    Lumiere Therapeutics’s primary industry is Drug Discovery.

  • Is Lumiere Therapeutics a private or public company?

    Lumiere Therapeutics is a Private company.

  • What is Lumiere Therapeutics’s current revenue?

    The current revenue for Lumiere Therapeutics is .

  • How much funding has Lumiere Therapeutics raised over time?

    Lumiere Therapeutics has raised $26.6M.

  • Who are Lumiere Therapeutics’s investors?

    Essential Capital (China), Hangzhou Huafang Chuanghuang Investment Management, Nanjing Innovation Capital Group, Guangzhou Industrial Investment Holding Group, and Apricot Capital (Shanghai) are 5 of 6 investors who have invested in Lumiere Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process